Table 3 Estimated total annual costs and effects of cervical screening in Australia, excluding overheads (all costs in Australian dollars)
| Â | Annual costs to health care system | Direct cytology cost component | Discounted lifetime cost (5% discount rate) | Discounted life-years (5% discount rate) | Cost-effectiveness ratio compared to no intervention |
|---|---|---|---|---|---|
No intervention | $34.7M* | - | $52.1* | 18.8619 | - |
Current practice, 2-yearly recommendation | $166.7M | $37.4 M (22%) | $416.7 | 18.8723 | $35,000/LYS |
Continue reminder system, 3-yearly recommendation | $156.7M | $34.4 M (22%) | $396.4 | 18.8723 | $33,000/LYS |
Call-and-recall, 3-yearly recommendation | $148.8M | $32.3 (22%) | $373.8 | 18.8723 | $31,000/LYS |